Because of the history of previous lack of success coupled with a lot of recent resignations i guess?? Isnt that around 25 million from the market just in the last few years with still no "data packs" and no results on 2nd gen fpp's. I notice we compared pyc to peptidream in the past. Look at them go, just collaboration after collaboration. Seems japanese pharma are more open to working together for a common goal. It was a shame when Mr Hayes went as i was hoping he would be the one to get us thro the door in USA.
https://www.businesswire.com/news/home/20180925006299/en/PeptiDream-Announces-Drug-Discovery-Development-Agreement-Santen
https://www.businesswire.com/news/home/20190123005292/en/PeptiDream-Announces-New-Peptide-Drug-Conjugate-PDC
Because of the history of previous lack of success coupled with...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.24 |
Change
0.040(3.33%) |
Mkt cap ! $723.2M | |||
| Open | High | Low | Value | Volume |
| $1.20 | $1.24 | $1.19 | $1.500M | 1.241M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 204320 | $1.24 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.25 | 4333 | 2 |
View Market Depth
| Last trade - 16.11pm 24/06/2025 (20 minute delay) ? |
| PYC (ASX) Chart |